ST Premium

For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market.Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.

Ready to Win Big?

Try Now for Just $1!

APLT Company Profile and Key Details

NASDAQ : APLT

Applied Therapeutics, Inc.

$0.33

0.0292+9.61%

At Close 4:00 PM

60.74

BESG ScoreESG Rating

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

Price Chart

Stock Price Today

Applied Therapeutics, Inc. (APLT) stock surged +9.61%, trading at $0.33 on NASDAQ, up from the previous close of $0.30. The stock opened at $0.31, fluctuating between $0.31 and $0.35 in the recent session.

Stock Snapshot

0.3038

Prev. Close

0.31

Open

47.14M

Market Cap

141.58M

Number of Shares

0.3121

Day Low

0.3463

Day High

-0.44

P/E Ratio

78.43%

Free Float in %

-0.76

EPS (TTM)

-0.2

Book Value

-0.65

Cash Flow per Share

1.73M

Volume

Relevant Articles

SEC Fillings

Current Report (8-k)

Filing Date	Accepted Date

Annual Report (10-k)

Filing Date	Accepted Date

Stock Price History Chart

Date	Open	High	Low	Close	Volume
Apr 17, 2025	0.31	0.35	0.31	0.33	1.75M
Apr 16, 2025	0.33	0.33	0.30	0.30	3.38M
Apr 15, 2025	0.37	0.38	0.33	0.33	1.82M
Apr 14, 2025	0.38	0.38	0.34	0.37	1.39M
Apr 11, 2025	0.33	0.38	0.32	0.37	1.54M
Apr 10, 2025	0.32	0.35	0.31	0.32	1.28M
Apr 09, 2025	0.35	0.36	0.30	0.32	4.61M
Apr 08, 2025	0.42	0.42	0.34	0.35	2.42M
Apr 07, 2025	0.42	0.43	0.36	0.41	3.64M
Apr 04, 2025	0.41	0.45	0.40	0.43	6.19M
Apr 03, 2025	0.42	0.44	0.40	0.41	1.86M
Apr 02, 2025	0.44	0.46	0.44	0.44	1.82M
Apr 01, 2025	0.50	0.50	0.46	0.46	1.36M
Mar 31, 2025	0.50	0.52	0.45	0.49	1.71M
Mar 28, 2025	0.54	0.56	0.52	0.52	719.32K
Mar 27, 2025	0.53	0.56	0.52	0.54	1.16M
Mar 26, 2025	0.54	0.56	0.52	0.52	530.01K
Mar 25, 2025	0.55	0.57	0.53	0.55	1.11M
Mar 24, 2025	0.57	0.60	0.55	0.56	1.63M
Mar 21, 2025	0.49	0.62	0.48	0.57	4.76M

Contact Details

New York, NY 10017

United States

Website: https://www.appliedtherapeutics.comContact: 212 220 9226

About Company

Applied Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel products to target cardiovascular disease, galactosemia, and diabetic complications. Its lead product candidate is AT-007 that has completed phase 1/2 for the treatment of galactosemia in healthy volunteers and adults, as well as is in pediatric clinical study for the treatment of galactosemia in kids; for treating sorbitol dehydrogenase deficiency; and for the treatment of phosphomannomutase enzyme-CDG. The company also develops AT-001 that is in phase III clinical trials for treating diabetic cardiomyopathy, as well as for the treatment of diabetic peripheral neuropathy. Its preclinical stage products include AT-003 for the treatment diabetic retinopathy; AT-104, a PI3K inhibitor for treating orphan hematological oncology T Cell Acute Lymphoblastic Leukemia. Applied Therapeutics, Inc. was incorporated in 2016 and is headquartered in New York, New York.

Frequently Asked Questions

What is the current Applied Therapeutics, Inc. (APLT) stock price?

Applied Therapeutics, Inc. (NASDAQ: APLT) stock price is $0.33 in the last trading session. During the trading session, APLT stock reached the peak price of $0.35 while $0.31 was the lowest point it dropped to. The percentage change in APLT stock occurred in the recent session was 9.61% while the dollar amount for the price change in APLT stock was $0.03.

APLT's industry and sector of operation?

The NASDAQ listed APLT is part of Biotechnology industry that operates in the broader Healthcare sector. Applied Therapeutics, Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of APLT?

Mr. Chids Mahadevan
Senior Vice President of Fin. & Interim Principal Financial Officer
Mr. Steven Ortega
Chief Accounting Officer & Interim Principal Financial Officer
Dr. Shoshana Shendelman Ph.D.
Chair of the Board of Directors, Founder, Pres, Chief Executive Officer & Sec.
Dr. Riccardo Perfetti M.D., Ph.D.
Chief Medical Officer
Mr. Adam Hansard
Chief Commercial Officer
Ms. Catherine Thorpe
Interim Principal Financial Officer & Chief Accounting Officer

How APLT did perform over past 52-week?

APLT's closing price is 12.88% higher than its 52-week low of $0.30 where as its distance from 52-week high of $10.62 is -96.87%.

How many employees does APLT have?

Number of APLT employees currently stands at 37.

Link for APLT official website?

Official Website of APLT is: https://www.appliedtherapeutics.com

How do I contact APLT?

APLT could be contacted at phone 212 220 9226 and can also be accessed through its website. APLT operates from 545 Fifth Avenue, New York, NY 10017, United States.

How many shares of APLT are traded daily?

APLT stock volume for the day was 1.73M shares. The average number of APLT shares traded daily for last 3 months was 2.54M.

What is the market cap of APLT currently?

The market value of APLT currently stands at $47.14M with its latest stock price at $0.33 and 141.58M of its shares outstanding.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

About

Home About Meet The Team Contact Us Privacy Policy Newsletter

News

Investing Crypto Market Business US Stocks

Useful Links

Screener Market Data Insider Transactions Upgrades & Downgrades 52 Week Highs & Lows Unusual Volume Dividend Calendar Earnings Calendar

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

Employees	37
Beta	1.89
Sales or Revenue	$9.99M
5Y Sales Change%	0%
Fiscal Year Ends	December
Sector	Healthcare
Industry	Biotechnology